Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials for Cancer in United States

7251 results

Sort By:

First-in-Human Study of OKI-219 in Advanced Solid Tumors and Advanced Breast Cancer

Study ID: NCT06239467
Start Date: 2024-02-26
End Date: 2027-08-01
Study Type

Interventional

Study Phase

Phase1

No. of Participants

150

Intervention / Treatment

OKI-219

Fulvestrant

Trastuzumab

Sponsor

OnKure, Inc.

Source: clinicaltrials.gov

Share:
Add to list

Exercise to ReGain Stamina and Energy (The EXERGISE Study)

Study ID: NCT05684367
Start Date: 2023-11-29
End Date: 2026-08
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

24

Intervention / Treatment

Center-Based Walking Exercise

Home-Based Walking Exercise

Sponsor

University of Florida

Source: clinicaltrials.gov

Share:
Add to list

Passive Music Intervention for the Reduction of Anxiety in Patients Undergoing Bone Marrow Aspiration and/or Biopsy

Study ID: NCT06169267
Start Date: 2024-04-22
End Date: 2025-06-19
Study Type

Interventional

Study Phase

Phase3

No. of Participants

110

Intervention / Treatment

Bone Marrow Aspiration

Bone Marrow Biopsy

Music Therapy

Administration questionnaire

Sponsor

City of Hope Medical Center

Source: clinicaltrials.gov

Share:
Add to list

Surgical Treatments for Postamputation Pain

Study ID: NCT05009394
Start Date: 2023-06-20
End Date: 2029-06
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

110

Intervention / Treatment

Targeted Muscle Reinnervation (TMR)

Regenerative Peripheral Nerve Interface (RPNI)

Standard neuroma treatment, neuroma excision, and muscle burying

Sponsor

Prometei Pain Rehabilitation Center

Source: clinicaltrials.gov

Share:
Add to list

Propranolol in Combination With Pembrolizumab and Standard Chemotherapy for the Treatment of Unresectable Locally Advanced or Metastatic Esophageal or Gastroesophageal Junction Adenocarcinoma

Study ID: NCT05651594
Start Date: 2023-03-07
End Date: 2026-03-30
Study Type

Interventional

Study Phase

Phase2

No. of Participants

40

Intervention / Treatment

Biopsy

Biospecimen Collection

Computed Tomography

Fluorouracil

Leucovorin

Oxaliplatin

Pembrolizumab

Propranolol Hydrochloride

Administration questionnaire

Sponsor

Roswell Park Cancer Institute

Source: clinicaltrials.gov

Share:
Add to list

Screening for AL Amyloidosis in Smoldering Multiple Myeloma

Study ID: NCT06365060
Start Date: 2024-05-01
End Date: 2029-02-27
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

400

Intervention / Treatment
Sponsor

Tufts Medical Center

Source: clinicaltrials.gov

Share:
Add to list

MEM-288 Oncolytic Virus Alone and in Combination With Standard of Care Therapy in Advanced Solid Tumors

Study ID: NCT05076760
Start Date: 2022-04-21
End Date: 2031-12
Study Type

Interventional

Study Phase

Phase1

No. of Participants

40

Intervention / Treatment

MEM-288 Intratumoral Injection

Nivolumab

Docetaxel

Sponsor

Memgen, Inc.

Source: clinicaltrials.gov

Share:
Add to list

Stereotactic Body Radiation Therapy or Intensity Modulated Radiation/Proton Therapy in Treating Patients With Recurrent Head and Neck Cancer

Study ID: NCT03164460
Start Date: 2017-05-22
End Date: 2025-05-31
Study Type

Interventional

Study Phase

Phase2

No. of Participants

100

Intervention / Treatment

Intensity-Modulated Radiation Therapy

Proton Radiation

Stereotactic Body Radiation Therapy

Sponsor

M.D. Anderson Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

A Study of Enfortumab Vedotin in People With Adenoid Cystic Carcinoma

Study ID: NCT06891560
Start Date: 2025-03-31
End Date: 2027-03
Study Type

Interventional

Study Phase

Phase2

No. of Participants

34

Intervention / Treatment

Emportumab Vedotin

Sponsor

Memorial Sloan Kettering Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

A Surgical Window of Opportunity Clinical Trial of Troriluzole in Recurrent IDH Wild-Type Glioblastoma

Study ID: NCT06552260
Start Date: 2025-02-19
End Date: 2027-08-01
Study Type

Interventional

Study Phase

Early_phase1

No. of Participants

27

Intervention / Treatment

Trroriluzole

Sponsor

Eudocia Quant Lee, MD

Source: clinicaltrials.gov

Share:
Add to list